PT827505E - Esteres de hidroxilo soluveis seleccionados contendo indolocarbazoles - Google Patents
Esteres de hidroxilo soluveis seleccionados contendo indolocarbazolesInfo
- Publication number
- PT827505E PT827505E PT96911556T PT96911556T PT827505E PT 827505 E PT827505 E PT 827505E PT 96911556 T PT96911556 T PT 96911556T PT 96911556 T PT96911556 T PT 96911556T PT 827505 E PT827505 E PT 827505E
- Authority
- PT
- Portugal
- Prior art keywords
- solued
- self
- esters containing
- hydroxyl esters
- indolocarbazoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/044—Pyrrole radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/06—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing nitrogen as ring hetero atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/417,611 US5650407A (en) | 1995-04-05 | 1995-04-05 | Selected soluble esters of hydroxyl-containing indolocarbazoles |
| US08/624,707 US5686444A (en) | 1995-04-05 | 1996-03-26 | Selected soluble esters of hydroxyl-containing indolocarbazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT827505E true PT827505E (pt) | 2003-01-31 |
Family
ID=27023791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT96911556T PT827505E (pt) | 1995-04-05 | 1996-04-03 | Esteres de hidroxilo soluveis seleccionados contendo indolocarbazoles |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US5686444A (pt) |
| EP (1) | EP0827505B1 (pt) |
| JP (1) | JPH11504623A (pt) |
| KR (1) | KR100429117B1 (pt) |
| AT (1) | ATE225793T1 (pt) |
| AU (1) | AU700658B2 (pt) |
| BR (1) | BR9608044A (pt) |
| CA (1) | CA2215111A1 (pt) |
| DE (1) | DE69624236T2 (pt) |
| DK (1) | DK0827505T3 (pt) |
| ES (1) | ES2183941T3 (pt) |
| HK (1) | HK1009370A1 (pt) |
| NO (1) | NO311575B1 (pt) |
| NZ (1) | NZ306205A (pt) |
| PT (1) | PT827505E (pt) |
| WO (1) | WO1996031515A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5686444A (en) | 1995-04-05 | 1997-11-11 | Cephalon, Inc. | Selected soluble esters of hydroxyl-containing indolocarbazoles |
| AU2012199A (en) * | 1997-12-24 | 1999-07-19 | Vertex Pharmaceuticals Incorporated | Prodrugs of aspartyl protease inhibitors |
| US6200968B1 (en) * | 1998-08-06 | 2001-03-13 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
| CN1329034C (zh) * | 1998-09-25 | 2007-08-01 | 赛福伦公司 | 预防/治疗感觉毛细胞和耳蜗神经元损伤的药物 |
| US7129250B2 (en) | 2000-05-19 | 2006-10-31 | Aegera Therapeutics Inc. | Neuroprotective and anti-proliferative compounds |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1500989A (fr) * | 1966-08-30 | 1967-11-10 | Produits cosmétiques pour les soins de la peau | |
| GB1317185A (en) * | 1969-06-20 | 1973-05-16 | Glaxo Lab Ltd | Acyloxy-3alpha-hydroxy-pregnones |
| US4534899A (en) * | 1981-07-20 | 1985-08-13 | Lipid Specialties, Inc. | Synthetic phospholipid compounds |
| US4894226A (en) * | 1986-11-14 | 1990-01-16 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polyproline conjugation |
| JPH0826036B2 (ja) * | 1987-01-22 | 1996-03-13 | 協和醗酵工業株式会社 | 生理活性物質ｋ−２５２の誘導体 |
| WO1988007045A1 (en) * | 1987-03-09 | 1988-09-22 | Kyowa Hakko Kogyo Co., Ltd. | Derivatives of physiologically active substance k-252 |
| JPH07113027B2 (ja) * | 1987-12-24 | 1995-12-06 | 協和醗酵工業株式会社 | Ｋ−２５２誘導体 |
| WO1993008809A1 (en) * | 1991-11-08 | 1993-05-13 | The University Of Southern California | Compositions containing k-252 compounds for potentiation of neurotrophin activity |
| US5461146A (en) * | 1992-07-24 | 1995-10-24 | Cephalon, Inc. | Selected protein kinase inhibitors for the treatment of neurological disorders |
| CA2123895A1 (en) * | 1992-09-21 | 1994-03-31 | Tatsuya Tamaoki | A therapeutic agent for thrombocytopenia |
| EP0643966A4 (en) * | 1993-03-03 | 1995-08-09 | Kyowa Hakko Kogyo Kk | SENSITIVITY BOOSTER FOR ANTINEOPLASTIC AGENT. |
| NZ267337A (en) * | 1993-05-28 | 2005-01-28 | Kyowa Hakko Kogyo Kk | Indolocarbazole derivatives and pharmaceutical compositions thereof |
| US5650407A (en) | 1995-04-05 | 1997-07-22 | Cephalon, Inc. | Selected soluble esters of hydroxyl-containing indolocarbazoles |
| US5686444A (en) | 1995-04-05 | 1997-11-11 | Cephalon, Inc. | Selected soluble esters of hydroxyl-containing indolocarbazoles |
-
1996
- 1996-03-26 US US08/624,707 patent/US5686444A/en not_active Ceased
- 1996-04-03 CA CA002215111A patent/CA2215111A1/en not_active Abandoned
- 1996-04-03 KR KR1019970706993A patent/KR100429117B1/ko not_active IP Right Cessation
- 1996-04-03 DE DE69624236T patent/DE69624236T2/de not_active Expired - Fee Related
- 1996-04-03 PT PT96911556T patent/PT827505E/pt unknown
- 1996-04-03 DK DK96911556T patent/DK0827505T3/da active
- 1996-04-03 JP JP8530454A patent/JPH11504623A/ja not_active Ceased
- 1996-04-03 ES ES96911556T patent/ES2183941T3/es not_active Expired - Lifetime
- 1996-04-03 AU AU54408/96A patent/AU700658B2/en not_active Ceased
- 1996-04-03 BR BRPI9608044-2A patent/BR9608044A/pt not_active IP Right Cessation
- 1996-04-03 NZ NZ306205A patent/NZ306205A/xx not_active IP Right Cessation
- 1996-04-03 EP EP96911556A patent/EP0827505B1/en not_active Expired - Lifetime
- 1996-04-03 WO PCT/US1996/004568 patent/WO1996031515A1/en active IP Right Grant
- 1996-04-03 AT AT96911556T patent/ATE225793T1/de not_active IP Right Cessation
-
1997
- 1997-10-03 NO NO19974580A patent/NO311575B1/no not_active IP Right Cessation
-
1998
- 1998-09-01 HK HK98110361A patent/HK1009370A1/xx not_active IP Right Cessation
-
2001
- 2001-03-19 US US09/811,725 patent/USRE38332E1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| NO311575B1 (no) | 2001-12-10 |
| EP0827505A1 (en) | 1998-03-11 |
| MX9707632A (es) | 1998-06-30 |
| ES2183941T3 (es) | 2003-04-01 |
| KR19980703588A (ko) | 1998-11-05 |
| US5686444A (en) | 1997-11-11 |
| NO974580L (no) | 1997-11-27 |
| DE69624236D1 (de) | 2002-11-14 |
| EP0827505A4 (en) | 1998-08-12 |
| NO974580D0 (no) | 1997-10-03 |
| AU5440896A (en) | 1996-10-23 |
| KR100429117B1 (ko) | 2004-07-19 |
| ATE225793T1 (de) | 2002-10-15 |
| USRE38332E1 (en) | 2003-11-25 |
| DE69624236T2 (de) | 2003-09-11 |
| HK1009370A1 (en) | 1999-06-04 |
| EP0827505B1 (en) | 2002-10-09 |
| DK0827505T3 (da) | 2003-02-17 |
| NZ306205A (en) | 2000-01-28 |
| AU700658B2 (en) | 1999-01-14 |
| WO1996031515A1 (en) | 1996-10-10 |
| JPH11504623A (ja) | 1999-04-27 |
| BR9608044A (pt) | 1999-01-26 |
| CA2215111A1 (en) | 1996-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT695758E (pt) | Amidas e esteres de pentapeptidos inibidores de cancro humano | |
| ES2186783T3 (es) | Derivados de la dolastatina, su preparacion y uso. | |
| TR199701567T1 (xx) | Rapamisin t�revleri. | |
| DE69524274D1 (de) | System zur Isolierung von Rückwandeinheiten | |
| AU4838097A (en) | Apparatus for the treatment of specimens | |
| MX9803792A (es) | Inhibidor de proteina cinasa c. | |
| AU4815197A (en) | Tetraphosphonate bicyclic trisanhydrides | |
| DE69630955T2 (de) | Immortalisierung bzw. desimmortalisierung von zellen | |
| DE69302634T2 (de) | Pfropfcopolymer, Verfahren zur Herstellung davon und dieses Copolymer als aktive Komponente enthaltende Weichmacher | |
| ATE372976T1 (de) | Illudin analoge verwendet als antitumormittel | |
| AU1575697A (en) | Compositions and methods for the treatment and diagnosis of cancer | |
| DE69735583D1 (de) | Semisynthetisches verfahren zur herstellung von didemninanalogen | |
| GEP20084346B (en) | Protein kinase c inhibitors | |
| PT827505E (pt) | Esteres de hidroxilo soluveis seleccionados contendo indolocarbazoles | |
| FI854910A0 (fi) | Anordning foer distortionsfri utstrykning av display under en enskild bild. | |
| DE69707533T2 (de) | Verfahren zur Herstellung von 3-Formyl-tetrahydrofuran | |
| AU6786898A (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders | |
| IT1283773B1 (it) | Procedimento per la perparazione di ammidi da ossime | |
| DE69707825D1 (de) | Verfahren zur Herstellung von alicyclischen Hydrazin-derivaten. | |
| IT1283454B1 (it) | Procedimento per la preparazione di ammidi da ossime | |
| AU8580598A (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders | |
| AU6786798A (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders | |
| EP0925064A4 (en) | 5-ANDROSTEN 3-beta, 17-alpha DIOL AS A TUMOR GROWTH INHIBITOR | |
| ATE223427T1 (de) | Modifizierte kojibioside analoge | |
| AU6786698A (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders |